Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec.

Diabetes, obesity & metabolism·2026

Same author

Prospective Cohort Study Evaluating Impact of Hemodialysis on Glycemia: BLOSSOM (Blood Sugar Sensing on Maintenance Dialysis) Cohort Findings.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same author

Insulin preservatives trigger neutrophil extracellular trap formation through SYNE1-mediated nuclear disassembly.

bioRxiv : the preprint server for biology·2026

Same author

Immunomodulatory Effects of Insulin-Derived Fibrils from Infusion Pumps: Role of Phenolic Preservatives in Macrophage Activation.

bioRxiv : the preprint server for biology·2026

Same author

What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort.

Diabetes, obesity & metabolism·2026

Same author

Tailored high-dose corticosteroids in patients with diabetes mellitus hospitalized with hypoxemic COVID-19 pneumonia: insights from the CocAA-CoLa Plus Study.

Minerva medica·2026

Same journal

Using a Fine-Tuned Commercial Artificial Intelligence Model to Assess Nutrients from Photographs of Japanese Meals.

Journal of diabetes science and technology·2026

Same journal

Diversity of Daily Glycemic Phenotypes Is Independently Associated With HbA1c: A Time-Resolved CGM Clustering Analysis.

Journal of diabetes science and technology·2026

Same journal

Continuous Glucose Monitoring and Early Dysglycemia: Toward an Emerging Stage Preceding Prediabetes.

Journal of diabetes science and technology·2026

Same journal

A Pilot Study on Disposal Practices and Environmental Awareness of Insulin-Related Devices Among People With Diabetes.

Journal of diabetes science and technology·2026

Same journal

Quality of In-Use Insulin Under Real-World Storage Conditions in Mwanza, Tanzania.

Journal of diabetes science and technology·2026

Same journal

Continuous Glucose Monitoring Metrics for Predicting Adverse Neonatal Outcomes in Individuals Undergoing Gestational Diabetes Screening.

Journal of diabetes science and technology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Published on: December 14, 2015

The DERMIS Study: Methodologies, Results, and Implications for the Future.

Irl B Hirsch¹, Dorrine Khakpour¹, Jeffrey Joseph²

¹Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

Journal of Diabetes Science and Technology

|December 5, 2024

Summary

This summary is machine-generated.

Infusion set issues hinder accurate insulin delivery, impacting automated insulin delivery (AID) systems. New research and a recent conference highlight the need for improved infusion set technology to enhance diabetes management.

Keywords:

catheter dermis inflammation insulin infusion set type 1 diabetes

More Related Videos

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

Related Experiment Videos

Last Updated: Jun 5, 2025

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Published on: December 14, 2015

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

Area of Science:

Diabetes Technology
Biomaterials Science
Medical Device Innovation

Background:

Automated insulin delivery (AID) systems represent significant advancements in diabetes management.
However, the efficacy of AID systems is limited by infusion set performance, often termed the 'Achilles heel'.
The DERMIS study identified significant biological changes at the infusion site, including inflammation and tissue damage.

Purpose of the Study:

To summarize the findings of the DERMIS study regarding infusion set complications.
To discuss testing methodologies and insights from a Helmsley Charitable Trust-sponsored conference.
To propose future research directions for developing improved insulin infusion sets.

Main Methods:

Review of the DERMIS study, which utilized optical coherence tomography (OCT) and histopathology.
Summary of discussions and findings from a dedicated conference on February 29, 2024.
Analysis of current challenges and proposed solutions for infusion set technology.

Main Results:

The DERMIS study revealed increased vessel density and inflammation via OCT.
Histopathology showed elevated inflammation, fat necrosis, fibrosis, and eosinophilic infiltration.
These findings underscore the biological impact of current infusion set technology.

Conclusions:

Infusion set complications significantly affect insulin delivery accuracy and device usability.
Further research is crucial to understand and mitigate infusion site reactions.
Developing novel infusion sets is essential to reduce insulin delivery variability and extend wear time for better diabetes control.